[13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

C53H39N5OPt-2 — CID 171724175

IUPAC[13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3[c-]c(Oc4[c-]c(-n5cc6c7cnc(n6c5=[Pt])CCc5ccc(cc5)CC7)ccc4)ccc3c3cc(-c4ccccc4)ccc32)nc(C)c1-c1ccccc1
InChIInChI=1S/C53H39N5O.Pt/c1-35-28-52(55-36(2)53(35)40-12-7-4-8-13-40)58-48-26-23-41(39-10-5-3-6-11-39)29-47(48)46-25-24-45(31-49(46)58)59-44-15-9-14-43(30-44)56-33-50-42-22-20-37-16-18-38(19-17-37)21-27-51(54-32-42)57(50)34-56;/h3-19,23-26,28-29,32-33H,20-22,27H2,1-2H3;/q-2;
InChIKeyHMDXMBXGXROGID-UHFFFAOYSA-N
MW957.01 g/mol
LogP11.92
Rot. Bonds6

About [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum

[13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (PubChem CID 171724175) has the molecular formula C53H39N5OPt-2 and a molecular weight of 957.01 g/mol. Its IUPAC name is [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.

Molecular Properties

Compound Name[13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
PubChem CID171724175
Molecular FormulaC53H39N5OPt-2
Molecular Weight957.01 g/mol
Exact Mass956.28
IUPAC Name[13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum
SMILESCc1cc(-n2c3[c-]c(Oc4[c-]c(-n5cc6c7cnc(n6c5=[Pt])CCc5ccc(cc5)CC7)ccc4)ccc3c3cc(-c4ccccc4)ccc32)nc(C)c1-c1ccccc1
InChIInChI=1S/C53H39N5O.Pt/c1-35-28-52(55-36(2)53(35)40-12-7-4-8-13-40)58-48-26-23-41(39-10-5-3-6-11-39)29-47(48)46-25-24-45(31-49(46)58)59-44-15-9-14-43(30-44)56-33-50-42-22-20-37-16-18-38(19-17-37)21-27-51(54-32-42)57(50)34-56;/h3-19,23-26,28-29,32-33H,20-22,27H2,1-2H3;/q-2;
InChIKeyHMDXMBXGXROGID-UHFFFAOYSA-N
XLogP11.92
TPSA49.28 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms60
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500957.01
LogP ≤ 511.92
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The IUPAC name of [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum (CID 171724175) is [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum.
What is the SMILES notation for [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The canonical SMILES for [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is Cc1cc(-n2c3[c-]c(Oc4[c-]c(-n5cc6c7cnc(n6c5=[Pt])CCc5ccc(cc5)CC7)ccc4)ccc3c3cc(-c4ccccc4)ccc32)nc(C)c1-c1ccccc1.
What is the InChIKey of [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
The InChIKey is HMDXMBXGXROGID-UHFFFAOYSA-N. The full InChI is InChI=1S/C53H39N5O.Pt/c1-35-28-52(55-36(2)53(35)40-12-7-4-8-13-40)58-48-26-23-41(39-10-5-3-6-11-39)29-47(48)46-25-24-45(31-49(46)58)59-44-15-9-14-43(30-44)56-33-50-42-22-20-37-16-18-38(19-17-37)21-27-51(54-32-42)57(50)34-56;/h3-19,23-26,28-29,32-33H,20-22,27H2,1-2H3;/q-2;.
What are the key properties of [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum?
[13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum has a molecular weight of 957.01 g/mol, XLogP of 11.92, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [13-[3-[[9-(4,6-dimethyl-5-phenyl-2-pyridinyl)-6-phenyl-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-11,13,17-triazatetracyclo[8.5.2.24,7.011,15]nonadeca-1(16),4,6,10(17),14,18-hexaen-12-ylidene]platinum is sourced from PubChem (CID 171724175), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).